Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-03-06 @ 11:46 PM
Study NCT ID:
NCT04088734
Status:
TERMINATED
Last Update Posted:
2023-07-25
First Post:
2019-09-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease
Sponsor:
Ultragenyx Pharmaceutical Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-18
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-11
First Submit QC Date:
None
Study First Post Date:
2019-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-09
Results First Submit QC Date:
None
Results First Post Date:
2023-07-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-07-25
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-07-02
Last Update Post Date:
2023-07-25
Last Update Post Date Type:
ACTUAL